Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 3/20 | 0.49 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | MMP13 | P45452 | 1/20 | 0.45 |
| ▸ | DDR1 | Q08345 | 2/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | HSP90B1 | P14625 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.42 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6168334 | 0.86 | SLC22A12 (0.46) | KDM4ESMN1; SMN2POLBHSD17B10TSHR | |
| SCHEMBL2117651 | 0.85 | MMP13 (0.48) | KDM4ESMN1; SMN2POLBHSD17B10MMP13 | |
| SCHEMBL6698476 | 0.83 | MMP13 (0.60) | KDM4ESMN1; SMN2POLBHSD17B10TSHR | |
| SCHEMBL28573114 | 0.83 | HDAC6 (0.58) | CYP11B1CYP11B2KDM4EHSP90AA1HSP90B1 | |
| SCHEMBL30185531 | 0.83 | HDAC6 (0.58) | CYP11B1CYP11B2KDM4EHSP90AA1HSP90B1 | |
| SCHEMBL6701010 | 0.83 | CA1 (0.46) | KDM4ESMN1; SMN2POLBHSD17B10ALDH1A1 | |
| SCHEMBL6168393 | 0.83 | LMNA (0.46) | KDM4ESMN1; SMN2POLBHSD17B10MMP13 | |
| SCHEMBL6699408 | 0.82 | POLB (0.49) | KDM4EPOLBMMP13ALDH1A1LMNA | |
| SCHEMBL6697238 | 0.81 | PDPK1 (0.43) | KDM4ESMN1; SMN2POLBHSD17B10ALDH1A1 | |
| SCHEMBL6178153 | 0.81 | MAPK8 (0.53) | SMN1; SMN2MMP13ALDH1A1LMNAMAPK10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040044000-A1 | Isoquinoline derivatives as matrix metalloproteinase inhibitors | BUNKER AMY MAE (US) | 2004-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040044000-A1 | Isoquinoline derivatives as matrix metalloproteinase inhibitors | MMP1, MMP13, MMP9 | CYP11B1 72/4885CYP11B2 58/4885KDM4E 1326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.